研究单位：[1]Jiangsu HengRui Medicine Co., Ltd.[2]Phase I Unit of Tongji Hospital affilated Tongji Medical School of Huangzhong Science and Thechnology
研究目的：
The purpose of the study is to investigate the potential interaction between multiple oral doses of SHR3824 and multiple oral doses of SP2086 in healthy adult volunteers.
